A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients
Thomas Yau, Paul N. Cheng, Joanne Chiu, Gerry Gin Wai Kwok, Roland Leung, Angela M. Liu, Tan To Cheung, Chi Tao Ng
Topics & Concepts
MedicineOxaliplatinTolerabilityCapecitabineInternal medicineAdverse effectMucositisGastroenterologyNauseaResponse Evaluation Criteria in Solid TumorsChemotherapyPhases of clinical researchVomitingRashSurgeryCancerColorectal cancerCancer Research and TreatmentsCancer, Hypoxia, and MetabolismHepatocellular Carcinoma Treatment and Prognosis